Severe maternal morbidity and mortality index · women who are not yet pregnant and women in the early stages of pregnancy
Calcium supplementation showed no clear difference in severe maternal morbidity and mortality index compared with placebo (maternal outcomes) commencing before or early (low certainty).
1 finding from 1 review
Pregnancy loss or stillbirth at any gestational age · women who are not yet pregnant and women in the early stages of pregnancy
Calcium supplementation showed no clear difference in pregnancy loss or stillbirth at any gestational age compared with placebo (maternal outcomes) commencing before or early (low certainty).
1 finding from 1 review
Caesarean section · women who are not yet pregnant and women in the early stages of pregnancy
Calcium supplementation showed no clear difference in caesarean section compared with placebo (maternal outcomes) commencing before or early (low certainty).
1 finding from 1 review
Clinical failure · Children with extensive decay involving the dental pulp in primary teeth
Calcium hydroxide/iodoform (CH/iodoform) showed no clear difference in clinical failure compared with calcium hydroxide (CH); GRADE not reported.
1 finding from 1 review
Radiological failure · Children with extensive decay involving the dental pulp in primary teeth
Calcium hydroxide/iodoform (CH/iodoform) showed no clear difference in radiological failure compared with calcium hydroxide (CH); GRADE not reported.
1 finding from 1 review
Clinical failure · Children with extensive decay involving the dental pulp in primary teeth
Sealapex (eugenol-free calcium hydroxide) showed no clear difference in clinical failure compared with calcium hydroxide (CH); GRADE not reported.
1 finding from 1 review
Radiological failure · Children with extensive decay involving the dental pulp in primary teeth
Sealapex (eugenol-free calcium hydroxide) showed no clear difference in radiological failure compared with calcium hydroxide (CH); GRADE not reported.
1 finding from 1 review
Migraine frequency Number of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Duration of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · patients with Raynaud's phenomenon
1 finding from 1 review
Patient global Disability due to Raynaud's assessed on a 10‐cm visual analogue scale (0 = no disability, 10 = maximal disability) · patients with Raynaud's phenomenon
1 finding from 1 review
Withdrawals due to adverse events · patients with Raynaud's phenomenon
Calcium channel blockers showed no clear difference in number of withdrawals due to adverse events Number of participants… compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events Number of participants who died or withdrew and were hospitalized as a result of adverse effects of treatment · patients with Raynaud's phenomenon
1 finding from 1 review
Death or dependency at end of · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death at the end of treatment · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in death at the end of treatment compared with placebo (low certainty).
1 finding from 1 review
Death at the end of · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in death at the end of compared with placebo (low certainty).
1 finding from 1 review
Recurrence of stroke at the end of · people with acute ischemic stroke
1 finding from 1 review
Adverse events during treatment period · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in adverse events during treatment period compared with placebo (low certainty).
1 finding from 1 review
Hypotension · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in hypotension during treatment period compared with placebo (low certainty).
1 finding from 1 review